Discouraging treatment because of carbon emissions should be based on facts

The logical extension of the claim is that PBS pricing policies influence the carbon emissions produced by pharmaceuticals. Do the emissions fall by 25 per cent when a patent expires and a generic or biosimilar is launched? …